A proposed MHRA framework would combine clinical trial and marketing authorisation approval, potentially cutting years from drug development.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/new-licensing-route-could-speed-rare-disease-drug-access-2026a1000gje?src=rss
Author :
Publish date : 2026-05-21 13:31:00
Copyright for syndicated content belongs to the linked Source.
